The relationship between hypoglycemia in T2DM and cardiovascular outcome was independent of traditional CV risk factors and the value of several biomarkers, including high-sensitivity troponin T, NT-proBNP, and C-reactive protein. This evidence concerns the gene CRP and Hypoglycemia.